Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50
Closed -$1.27K 111
2025
Q1
$1.27K Buy
+50
New +$1.31K ﹤0.01% 128
2024
Q3
Sell
-1
Closed -$33 100
2024
Q2
$33 Buy
+1
New +$28 ﹤0.01% 127
2019
Q1
Sell
-42,668
Closed -$1.77M 106
2018
Q4
$1.77M Sell
42,668
-4,260
-9% -$177K 3.72% 9
2018
Q3
$1.96M Buy
+46,928
New +$1.81M 1.33% 25
2015
Q2
Sell
-23,390
Closed -$772K 29
2015
Q1
$772K Buy
+23,390
New +$744K 1.25% 17

Other funds holding PFE

HWG Holdings's PFE Position: Q2 2025 in Review

HWG Holdings sold out of Pfizer (PFE) in Q2 2025, closing a stake of 50 shares — an estimated $1.27K sold.

HWG Holdings first reported a position in PFE in Q1 2015 and held it in 5 quarters. The position peaked at $1.96M in Q3 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • HWG Holdings reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • HWG Holdings sold 50 Pfizer shares in Q2 2025, an estimated $1.27K.
  • HWG Holdings first reported a position in Pfizer in Q1 2015 and held it in 5 quarters.
  • HWG Holdings's Pfizer position peaked at $1.96M in Q3 2018.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on HWG Holdings's 13F filing for Q2 2025, filed 10 Jul 2025.